Cited by

• Calcium pyrophosphate crystal deposition in the ligamentum flavum of degenerated lumbar spine: histopathological and immunohistological findings.

  Yayama T, Kobayashi S, Sato R, Uchida K, Kokubo Y, Nakajima H, Takamura T, Mwaka E, Orwotho N, Baba H. Yayama T, et al. Clin Rheumatol. 2008 May;27(5):597-604. doi: 10.1007/s10067-007-0754-3. Epub 2007 Oct 13. Clin Rheumatol. 2008. PMID: 17934688
• Multilevel calcium pyrophosphate dihydrate deposition in cervical ligamentum flavum: clinical characteristics and imaging features.

  Lu YH, Lin HH, Chen HY, Chou PH, Wang ST, Liu CL, Chang MC. Lu YH, et al. BMC Musculoskelet Disord. 2021 Nov 4;22(1):929. doi: 10.1186/s12891-021-04812-6. BMC Musculoskelet Disord. 2021. PMID: 34736450 Free PMC article.
• Phosphocitrate is potentially a disease-modifying drug for noncrystal-associated osteoarthritis.

  Sun Y, Mauerhan DR, Franklin AM, Norton J, Hanley EN Jr, Gruber HE. Sun Y, et al. Biomed Res Int. 2013;2013:326267. doi: 10.1155/2013/326267. Epub 2013 Feb 21. Biomed Res Int. 2013. PMID: 23555081 Free PMC article.
• Cervical myelopathy due to subaxial calcium pyrophosphate dihydrate (CPPD) deposition with simultaneous asymptomatic crowned dens syndrome: two case reports.

  Chang DG, Park JB, Jung HY, Seo KJ. Chang DG, et al. BMC Musculoskelet Disord. 2020 Oct 31;21(1):713. doi: 10.1186/s12891-020-03736-x. BMC Musculoskelet Disord. 2020. PMID: 33129302 Free PMC article.
• Pathogenesis of chondrocalcinosis and pseudogout. Metabolism of inorganic pyrophosphate and production of calcium pyrophosphate dihydrate crystals.

  Caswell A, Guilland-Cumming DF, Hearn PR, McGuire MK, Russell RG. Caswell A, et al. Ann Rheum Dis. 1983 Aug;42 Suppl 1(Suppl 1):27-37. doi: 10.1136/ard.42.suppl_1.27. Ann Rheum Dis. 1983. PMID: 6311118 Free PMC article. Review. No abstract available.